With its core commercialization capabilities in category insights, brand building, digital marketing, and ecological organization collaboration, Baheal Pharma Group has constructed a brand commercialization platform (Stock code 301015.SZ) to provide upstream manufacturers with omni-channel commercialization solutions. With more than ten years of unremitting efforts, Baheal Pharma Group has incubated several leading brands in multiple categories, and has established a robust marketing network and stable collaborations with hundreds of upstream companies. Its product matrix covers five major product categories of OTC and General Health, RX, Cosmeceutical Skincare Products, Medical Devices, IVD.
OTC and General Health
A leading brand of calcium supplements meeting global quality standards for 20+ years, high quality raw materials and production from US, leading position of calcium supplements sales revenue in Chinese market for 5+ years.
An US dietary supplements brand, specialized in the development and production of natural, organic, and high-potency dietary supplements.

Used for alleviating symptoms of dry eyes.


Nourishing qi and yin while calming the mind, this remedy is prescribed for exhaustion stemming from qi and Yin deficiencies, as well as symptoms like heart palpitations, breathlessness, weak voice, dizziness, hot flashes, night sweats, tinnitus and forgetfulness, irritability and insomnia. "

RX
Compound Azintamide Enteric-coated Tablets, Pancreatin supplement with simethicone, effectively promote choleretic, quickly eliminate abdominal distension, effectively relieve indigestion symptoms such as loss of appetite, abdominal discomfort, early satiety, belching, fatty stool, chemical indigestion, etc.
Enrolled in China National Reimbursement Drug List (NRDL) category B list, level I medical evidence. First anti-hepatic fibrosis therapeutic drug recommended in six Major Guidelines or Consensuses. First FDA Phase II clinical trial completed Chinese proprietary therapeutic drug for hepatopathy. Substantial clinical evidence shows the efficacy of preventing and treating hepatic fibrosis, liver cirrhosis.
A novel extended-released Metformin formulated with osmotic pump-controlled technology. Once-daily formulation provides nearly constant release with stable blood drug concentrations throughout the day. It offers long-lasting and steady glucose-lowering effects with less gastrointestinal side effects.
High-quality Nifedipine extended-released tablets for managing hypertension and coronary heart disease. Passed the bioequivalence evaluation of NMPA.
Cosmeceutical Skincare Products
Micro-needle eye mask, applying the "transdermal drug delivery technology” originated from a key invention of a Japanese medical laboratory, enabling users to have medical-level care at home. Medical evidence shows safe and effective release of worries about trauma, pain, escharotic and reconstruction. With simple ingredients, high efficacy and 40+ patents, it effectively relieves the symptoms of dark circles, fine lines around the eyes, etc.
A leading brand of medical skin care originated from Sato Pharm, Japan, with unique basal repair components, DDS drug extended-released osmosis technology, Sato Pharm’s exclusive ointment technology, plant essence extraction and mixing technology. Excellula enables in-depth skin care, exploring the potential of skin cells, stimulating healthy beauty from inner skin.
A comprehensive skin-care brand, owned by Daiichi Sankyo, focusing on the research of "Tranexamic Acid" to reduce melanin synthesis and skin dark spots. Based on the research and validation of Dermatology, offering multiple treatments of skin problems such as dark spots, dry and rough skin, beneficial to refreshment of original beauty.
Medical Devices

The CH-VAD®, a Left Ventricular Assist Device (LVAD), represents an innovative approach to addressing the unmet clinical needs in advanced heart failure care. The solution has been designed to augment blood flow, enhance patient comfort, and minimize complications, all while prioritizing patient well-being. It is designed to reduce the occurrence of adverse events associated with advanced heart failure treatment, providing patients with peace of mind and the invaluable gift of more time to enjoy life.


Diverging from existing clinical electromagnetic navigation devices that integrate with medical imaging such as DSA and CT scans, this device revolutionizes electromagnetic localization technology. By seamlessly integrating electromagnetic navigation with ultrasound imaging, it achieves real-time visualization throughout the entirety of interventional procedures. With navigation accuracy ≤1.5mm, it boasts significant advantages in high-difficulty deep-seated punctures involving organs such as the liver, gallbladder, kidneys, and prostate. Clinical trial reports indicate a 98.96% success rate for single needle puncture procedures using this device. Furthermore, it reduces the learning curve for high-difficulty puncture procedures and enhances the accessibility of procedures such as TIPS (Transjugular Intrahepatic Porto-systemic Shunt).
The portable and user-friendly 3rd-generation Heartpal ECG Device is characterized for its lightweight design, easily operability even by non-professionals at any time and place. Moreover, the one-touch functioanlity allows immediate access to healthcare providers for ECG reading and online consultation services. This ensures users can quickly obtain medicial expert advice, highlighting the key product features of ease of use, rapid detection, and comprehensive functionality.
IVD

The assay kit is for in vitro qualitative test of EB virus Rta protein IgG antibodies in human serum.


The assay kit ia a indirect enzyme-linked immunoassay (ELISA)to detect EB virus Rta-IgG antibodies in human serum.


CE and NMPA certified


The assay kit is for in vitro qualitative test of EB virus capsid antigen (VCA)IgA antibodies in human serum.


The assay kit ia an enzyme-linked immunosorbent assay (ELISA)to qualitatively detect EBV VCA IgA antibodies in human serum and can aid in the diagnosis of  nasopharyngeal carcinoma.


CE and NMPA certified


The assay kit is for in vitro qualitative test of EB Virus early antigen (EA)IgA antibodies in human serum.


The assay kit is an enzyme-linked immunosorbent assay (ELISA)to qualitatively detect EBV early antigen (EA)IgA antibodies in human serum and can aid in the diagnosis of nasopharyngeal carcinoma.


CE and NMPA certified


This Mycobacterium leprae nucleic acid detection kit was jointly developed by the Institute of Dermatology,Chinese Academy of Medical Sciences and Func Biotech,a wholly-owned subsidiary of Baheal Biodiagnostics.It can rapidly diagnose individuals with multibacillary and paucibacillary leprosy,or those suspected of having leprosy,provide timely treatment,and effectively prevent spread of the disease and occurrence of disability.


The assay kit is based on multiple fluorescence PCR technology,providing important guidance for early diagnosis,prevention and treatment of leprosy.


Specification:24 tests/kit,48 tests/kit


CE Certified

The assay kit is for the in vitro qualitative detection of the HLA-B*13:01 allele in human blood samples.This product aids in guiding medication for patients intending to use dapsone for the treatment of leprosy,autoimmune bullous diseases,vasculitis and other diseases to avoid the adverse reactions of dapsone syndrome.


The assay kit is based on fluorescent PCR technology


Specification:96 tests/kit


CE Certified


The assay kit is utilized for in vitro qualitative detection of the F3L gene of suspected monkeypox cases,or other specimen samples (such as rash,scab,blister fluid,pustule fluid,or anticoagulated whole blood specimens)necessitatingdiagnosis and recognition.


The assay kit is based on fluorescent PCR technology


Specification:96 tests/kit


CE Certified


The assay kit is for the measurement of BP180 antibody in serum samples.


The BP180 Antibody Detection Kit(ELISA)uses the enzyme-linked immunosorbentassay (ELISA)for in vitro diagnosis as a supplementary technique in diagnosingbullous pemphigoid (BP)


CE Certified


Specification:96 tests/kit


The assay kit is for the measurement of BP180 antibody in serum samples


The BP230 Antibody Detection Kit(ELISA)uses enzyme-linked immunosorbent assay (ELISA)for in vitro diagnosis as a supplementary technique in diagnosing bullous pemphigoid(BP).


CE Certified


Specification:96 tests/kit


The assay kit is for the measurement Jo-1 antibody in serum samples.


Jo-1 Antibody Detection kit (ELISA)uses enzyme-linked immunosorbent assay (ELISA)for in vitro diagnosis as a supplementary technique in diagnosing  polymyositis(PM)and dermatomyositis (DM).


CE Certified


Specification:96 tests/kit


The assay kit is for the measurement of Melanoma differentiation gene 5 antibody n serum or plasma samples.


The MDA5 Antibody Detection kit (ELISA)uses enzyme-linked immunosorbent assay (ELISA)for in vitro diagnosis as a supplementary technique in diagnosing Dermatomyositis related diseases


CE Certified


Specification:96 tests/kit


The assay kit is used for the qualatitive measurement of TIF1-y antibody in serum samples.


The TIF-γ Antibody Detection kit (ELISA)uses enzyme-linked immunosorbent assay (ELISA)for in vitro diagnosis as a supplementary identification technique in diagnosing Dermatomyositis related diseases.


CE Certified


Specification:96 tests/kit


Back to Top